ICE regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ICE regimen, covering 2022-09-14 to 2022-09-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy [Phase 3]